Skip to Content
77 Mass Ave

Sepsis detector

A biosensor helps speed diagnosis.
October 24, 2019
Crystal structure of IL-6 as published in the Protein Data Bank
Crystal structure of IL-6 as published in the Protein Data BankWikimedia Commons

Time matters when treating sepsis, a leading cause of death in US hospitals that kills nearly 250,000 patients annually. Now an MIT-invented biosensor could help doctors diagnose the condition in minutes instead of hours.

With sepsis, the immune response to infection triggers a chain reaction of inflammation, causing elevated heart rate, high fever, and shortness of breath. If unchecked, it can lead to septic shock, where blood pressure falls and organs shut down.

Traditional lab tests and tools that diagnose sepsis can take hours. But the protein interleukin-6 (IL-6) is a promising early biomarker. Levels rise sharply in blood in response to inflammation, which can occur long before other symptoms appear. Concentrations of IL-6, however, are still too low for traditional assays to detect quickly.

The MIT researchers’ microfluidic sensor automatically detects clinically significant levels of IL-6 in about 25 minutes, using blood that can be collected from a finger prick. In one microfluidic channel, microbeads laced with antibodies and enzymes mix with a blood sample to capture IL-6 proteins. In another channel, only beads containing the biomarker attach to an electrode. Running voltage through the electrode produces an electrical signal for each biomarker-laced bead. The signals are combined and converted into a quantifiable measure of the biomarker.

“Doctors just load in a blood sample using a pipette. Then they press a button, and 25 minutes later they know the IL-6 concentration,” says first author Dan Wu, a PhD student in the Department of Mechanical Engineering.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.